Russell L Deter1, Wesley Lee1,2, Haleh Sangi-Haghpeykar1, John Kingdom3, Roberto Romero2,4,5,6. 1. a Department of Obstetrics and Gynecology , Texas Children's Hospital, Baylor College of Medicine , Houston , TX , USA. 2. b Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research , Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda , MD , USA. 3. c Division of Maternal Fetal Medicine , Mount Sinai Hospital, University of Toronto , Toronto , Canada. 4. d Department of Obstetrics and Gynecology , University of Michigan , Ann Arbor , MI , USA. 5. e Department of Epidemiology & Biostatistics , Michigan State University , East Lansing , MI , USA. 6. f Department of Molecular Obstetrics and Genetics , Wayne State University , Detroit , MI , USA.
Abstract
OBJECTIVE: To qualitatively and quantitatively characterize third trimester growth patterns in fetuses/neonates with growth restriction using Individualized Growth Assessment. METHODS: Serial fetal size measurements from 73 fetuses with proven growth restriction were evaluated using a novel composite parameter, the Fetal Growth Pathology Score (FGPS1). Third trimester FGPS1 measurements plotted against fetal age were examined for patterns. Identified patterns were characterized using the four components of the FGP1 [head circumference (HC), abdominal circumference (AC), femur diaphysis length (FDL), estimated weight (EWT)]. A secondary characterization using age of onset, duration and magnitude of the growth abnormality process was also performed. Frequencies and magnitudes of abnormal values in different FGPS1 patterns were compared. RESULTS: Five growth restriction patterns were found in 70/73 (95.9%) of the cases, with progressive worsening [Pattern 1 (37.0%)] and abnormal growth identified only at last scan [Pattern 2 (27.4%)] being the most common. These two patterns were usually statistically different from each other and the other three with respect to size parameter abnormalities and abnormal growth process characteristics (MANOVA). Growth abnormalities in all parameters of the FGPS1 contributed to the five abnormality patterns although AC and EWT were most important. The age of onset, duration and magnitude were similar between patterns except for Pattern 2, which had a late onset and a short duration (GLM + contrasts). CONCLUSIONS: Our study represents the first detailed evaluation of third trimester growth restriction using methods that consider the growth potential of each fetus. Five distinctive and repetitive patterns were found, suggesting that fetal growth restriction evolves in different ways. Further research is needed to determine the relationships of these patterns to physiological/biochemical changes and adverse outcomes associated with growth restriction.
OBJECTIVE: To qualitatively and quantitatively characterize third trimester growth patterns in fetuses/neonates with growth restriction using Individualized Growth Assessment. METHODS: Serial fetal size measurements from 73 fetuses with proven growth restriction were evaluated using a novel composite parameter, the Fetal Growth Pathology Score (FGPS1). Third trimester FGPS1 measurements plotted against fetal age were examined for patterns. Identified patterns were characterized using the four components of the FGP1 [head circumference (HC), abdominal circumference (AC), femur diaphysis length (FDL), estimated weight (EWT)]. A secondary characterization using age of onset, duration and magnitude of the growth abnormality process was also performed. Frequencies and magnitudes of abnormal values in different FGPS1 patterns were compared. RESULTS: Five growth restriction patterns were found in 70/73 (95.9%) of the cases, with progressive worsening [Pattern 1 (37.0%)] and abnormal growth identified only at last scan [Pattern 2 (27.4%)] being the most common. These two patterns were usually statistically different from each other and the other three with respect to size parameter abnormalities and abnormal growth process characteristics (MANOVA). Growth abnormalities in all parameters of the FGPS1 contributed to the five abnormality patterns although AC and EWT were most important. The age of onset, duration and magnitude were similar between patterns except for Pattern 2, which had a late onset and a short duration (GLM + contrasts). CONCLUSIONS: Our study represents the first detailed evaluation of third trimester growth restriction using methods that consider the growth potential of each fetus. Five distinctive and repetitive patterns were found, suggesting that fetal growth restriction evolves in different ways. Further research is needed to determine the relationships of these patterns to physiological/biochemical changes and adverse outcomes associated with growth restriction.
Entities:
Keywords:
Individualized growth assessment; SGA; longitudinal growth study
Authors: Edward D Barker; Fionnuala M McAuliffe; Fiona Alderdice; Julia Unterscheider; Sean Daly; Michael P Geary; Mairead M Kennelly; Keelin O'Donoghue; Alyson Hunter; John J Morrison; Gerard Burke; Patrick Dicker; Elizabeth C Tully; Fergal D Malone Journal: Obstet Gynecol Date: 2013-08 Impact factor: 7.661
Authors: Julia Unterscheider; Sean Daly; Michael Patrick Geary; Mairead Mary Kennelly; Fionnuala Mary McAuliffe; Keelin O'Donoghue; Alyson Hunter; John Joseph Morrison; Gerard Burke; Patrick Dicker; Elizabeth Catherine Tully; Fergal Desmond Malone Journal: Am J Obstet Gynecol Date: 2013-04 Impact factor: 8.661
Authors: Samantha J Benton; Lesley M McCowan; Alexander E P Heazell; David Grynspan; Jennifer A Hutcheon; Christof Senger; Orlaith Burke; Yuen Chan; Jane E Harding; Julien Yockell-Lelièvre; Yuxiang Hu; Lucy C Chappell; Melanie J Griffin; Andrew H Shennan; Laura A Magee; Andrée Gruslin; Peter von Dadelszen Journal: Placenta Date: 2016-03-23 Impact factor: 3.481
Authors: Aris T Papageorghiou; Eric O Ohuma; Douglas G Altman; Tullia Todros; Leila Cheikh Ismail; Ann Lambert; Yasmin A Jaffer; Enrico Bertino; Michael G Gravett; Manorama Purwar; J Alison Noble; Ruyan Pang; Cesar G Victora; Fernando C Barros; Maria Carvalho; Laurent J Salomon; Zulfiqar A Bhutta; Stephen H Kennedy; José Villar Journal: Lancet Date: 2014-09-06 Impact factor: 79.321
Authors: Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher Journal: Am J Obstet Gynecol Date: 2022-01-10 Impact factor: 10.693